Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Devi

Showing results (381-390 of 382) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 382 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2012
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBPShaoman Yin, Stefan Kaluz, Narra S Devi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 16, 2025
Comparing Stroke Profiles and Outcomes between Urban and Rural India: A Secondary Analysis of the SPRINT INDIA TrialShweta Jain Verma, Arya K S Devi, Deepti Arora, et al.
Pageof 39

Showing results (381-390 of 382) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 382 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2012
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBPShaoman Yin, Stefan Kaluz, Narra S Devi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 16, 2025
Comparing Stroke Profiles and Outcomes between Urban and Rural India: A Secondary Analysis of the SPRINT INDIA TrialShweta Jain Verma, Arya K S Devi, Deepti Arora, et al.
Pageof 39